Generation of knockout rabbits using transcription activator-like effector nucleases

Cell Regeneration

Volumn 3, Issue 1, 2014, Pages 3:3-

  Wang, Yu ^a   Fan, Nana ^a   Song, Jun ^a   Zhong, Juan ^a   Guo, Xiaogang ^a   Tian, Weihua ^a   Zhang, Quanjun ^a   Cui, Fenggong ^a   Li, Li ^a   Newsome, Philip N ^b,c   Frampton, Jon ^d   Esteban, Miguel A ^a   Lai, Liangxue ^a  

^a GUANGZHOU INSTITUTES OF BIOMEDICINE AND HEALTH   (China)

^b University Hospitals Birmingham NHS Foundation Trust   (United Kingdom)

^c QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^d UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Animal models; Genome editing; Knockout; Rabbits; TALENs; Transcription activator like effector nucleases; Zinc finger nucleases

Indexed keywords

TRANSCRIPTION ACTIVATOR LIKE EFFECTOR NUCLEASE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DNA MODIFICATION; DOUBLE STRANDED DNA BREAK; EMBRYO; FEMALE; GENE LOCUS; GENETIC ENGINEERING; IN VITRO STUDY; IN VIVO STUDY; KNOCKOUT GENE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; RABBIT;

ANIMALIA; ORYCTOLAGUS CUNICULUS; SUIDAE;

EID: 84988268323     PISSN: None     EISSN: 20459769     Source Type: Journal    
DOI: 10.1186/2045-9769-3-3     Document Type: Article

References (32)

1. Harding J, Roberts RM, Mirochnitchenko O. Large animal models for stem cell therapy. Stem Cell Res Ther 2013, 4:23. 10.1186/scrt171, 23672797.
2. Seok J, Warren HS, Cuenca AG, Mindrinos MN, Baker HV, Xu W, Richards DR, McDonald-Smith GP, Gao H, Hennessy L, Finnerty CC, Lopez CM, Honari S, Moore EE, Minei JP, Cuschieri J, Bankey PE, Johnson JL, Sperry J, Nathens AB, Billiar TR, West MA, Jeschke MG, Klein MB, Gamelli RL, Gibran NS, Brownstein BH, Miller-Graziano C, Calvano SE, Mason PH, et al. Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc Natl Acad Sci U S A 2013, 110:3507-3512. 10.1073/pnas.1222878110, 3587220, 23401516.
3. Rogers CS, Stoltz DA, Meyerholz DK, Ostedgaard LS, Rokhlina T, Taft PJ, Rogan MP, Pezzulo AA, Karp PH, Itani OA, Kabel AC, Wohlford-Lenane CL, Davis GJ, Hanfland RA, Smith TL, Samuel M, Wax D, Murphy CN, Rieke A, Whitworth K, Uc A, Starner TD, Brogden KA, Shilyansky J, McCray PB, Zabner J, Prather RS, Welsh MJ. Disruption of the CFTR gene produces a model of cystic fibrosis in newborn pigs. Science 2008, 321:1837-1841. 10.1126/science.1163600, 2570747, 18818360.
4. Chrenek P, Ryban L, Vetr H, Makarevich AV, Uhrin P, Paleyanda RK, Binder BR. Expression of recombinant human factor VIII in milk of several generations of transgenic rabbits. Transgenic Res 2007, 16:353-361. 10.1007/s11248-007-9070-6, 17265165.
5. Hu J, Qu J, Xu D, Zhang T, Qin L, Lu H. Combined application of low-intensity pulsed ultrasound and functional electrical stimulation accelerates bone-tendon junction healing in a rabbit model. J Orthop Res 2013, Epub ahead of print.
6. Kondo M, Sakai T, Komeima K, Kurimoto Y, Ueno S, Nishizawa Y, Usukura J, Fujikado T, Tano Y, Terasaki H. Generation of a transgenic rabbit model of retinal degeneration. Invest Ophthalmol Vis Sci 2009, 50:1371-1377.
7. Wang Y, Niimi M, Nishijima K, Waqar AB, Yu Y, Koike T, Kitajima S, Liu E, Inoue T, Kohashi M, Keyamura Y, Yoshikawa T, Zhang J, Ma L, Zha X, Watanabe T, Asada Y, Chen YE, Fan J. Human apolipoprotein A-II protects against diet-induced atherosclerosis in transgenic rabbits. Arterioscler Thromb Vasc Biol 2013, 33:224-231. 10.1161/ATVBAHA.112.300445, 3673010, 23241412.
8. Marian AJ, Wu Y, Lim DS, McCluggage M, Youker K, Yu QT, Brugada R, DeMayo F, Quinones M, Roberts R. A transgenic rabbit model for human hypertrophic cardiomyopathy. J Clin Invest 1999, 104:1683-1692. 10.1172/JCI7956, 409884, 10606622.
9. Evans MJ, Kaufman MH. Establishment in culture of pluripotential cells from mouse embryos. Nature 1981, 292:154-156. 10.1038/292154a0, 7242681.
10. Tancos Z, Nemes C, Polgar Z, Gocza E, Daniel N, Stout TA, Maraghechi P, Pirity MK, Osteil P, Tapponnier Y, Markossian S, Godet M, Afanassieff M, Bosze Z, Duranthon V, Savatier P, Dinnyes A. Generation of rabbit pluripotent stem cell lines. Theriogenology 2012, 78:1774-1786. 10.1016/j.theriogenology.2012.06.017, 22925641.
11. Schoonjans L, Albright GM, Li JL, Collen D, Moreadith RW. Pluripotential rabbit embryonic stem (ES) cells are capable of forming overt coat color chimeras following injection into blastocysts. Mol Reprod Dev 1996, 45:439-443. 10.1002/(SICI)1098-2795(199612)45:4<439::AID-MRD5>3.0.CO;2-S, 8956281.
12. Zakhartchenko V, Flisikowska T, Li S, Richter T, Wieland H, Durkovic M, Rottmann O, Kessler B, Gungor T, Brem G, Kind A, Wolf E, Schnieke A. Cell-mediated transgenesis in rabbits: chimeric and nuclear transfer animals. Biol Reprod 2011, 84:229-237. 10.1095/biolreprod.110.087098, 20944083.
13. Honda A, Hirose M, Hatori M, Matoba S, Miyoshi H, Inoue K, Ogura A. Generation of induced pluripotent stem cells in rabbits: potential experimental models for human regenerative medicine. J Biol Chem 2010, 285:31362-31369. 10.1074/jbc.M110.150540, 2951210, 20670936.
14. Osteil P, Tapponnier Y, Markossian S, Godet M, Schmaltz-Panneau B, Jouneau L, Cabau C, Joly T, Blachere T, Gocza E, Bernat A, Yerle M, Acloque H, Hidot S, Bosze Z, Duranthon V, Savatier P, Afanassieff M. Induced pluripotent stem cells derived from rabbits exhibit some characteristics of naive pluripotency. Biol Open 2013, 2:613-628. 10.1242/bio.20134242, 3683164, 23789112.
15. Cai J, Zhang Y, Liu P, Chen S, Wu X, Sun Y, Li A, Huang K, Luo R, Wang L. Generation of tooth-like structures from integration-free human urine induced pluripotent stem cells. Cell Regeneration 2013, 2:6.
16. Gardner RL, Munro AJ. Successful construction of chimaeric rabbit. Nature 1974, 250:146-147. 10.1038/250146a0, 4843134.
17. Lai L, Kolber-Simonds D, Park KW, Cheong HT, Greenstein JL, Im GS, Samuel M, Bonk A, Rieke A, Day BN, Murphy CN, Carter DB, Hawley RJ, Prather RS. Production of alpha-1,3-galactosyltransferase knockout pigs by nuclear transfer cloning. Science 2002, 295:1089-1092. 10.1126/science.1068228, 11778012.
18. Gaj T, Gersbach CA, Barbas CF. ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering. Trends Biotechnol 2013, 31:397-405. 10.1016/j.tibtech.2013.04.004, 23664777.
19. Kim YG, Cha J, Chandrasegaran S. Hybrid restriction enzymes: zinc finger fusions to Fok I cleavage domain. Proc Natl Acad Sci U S A 1996, 93:1156-1160. 10.1073/pnas.93.3.1156, 40048, 8577732.
20. Cermak T, Doyle EL, Christian M, Wang L, Zhang Y, Schmidt C, Baller JA, Somia NV, Bogdanove AJ, Voytas DF. Efficient design and assembly of custom TALEN and other TAL effector-based constructs for DNA targeting. Nucleic Acids Res 2011, 39:e82. 10.1093/nar/gkr218, 3130291, 21493687.
21. Flisikowska T, Thorey IS, Offner S, Ros F, Lifke V, Zeitler B, Rottmann O, Vincent A, Zhang L, Jenkins S, Niersbach H, Kind AJ, Gregory PD, Schnieke AE, Platzer J. Efficient immunoglobulin gene disruption and targeted replacement in rabbit using zinc finger nucleases. PLoS One 2011, 6:e21045. 10.1371/journal.pone.0021045, 3113902, 21695153.
22. Song J, Zhong J, Guo X, Chen Y, Zou Q, Huang J, Li X, Zhang Q, Jiang Z, Tang C, Yang H, Liu T, Li P, Pei D, Lai L. Generation of RAG 1- and 2-deficient rabbits by embryo microinjection of TALENs. Cell Res 2013, 23:1059-1062. 10.1038/cr.2013.85, 23835472.
23. Doyle EL, Booher NJ, Standage DS, Voytas DF, Brendel VP, Vandyk JK, Bogdanove AJ. TAL Effector-Nucleotide Targeter (TALE-NT) 2.0: tools for TAL effector design and target prediction. Nucleic Acids Res 2012, 40:W117-W122. 10.1093/nar/gks608, 3394250, 22693217.
24. Zhang F, Cong L, Lodato S, Kosuri S, Church GM, Arlotta P. Efficient construction of sequence-specific TAL effectors for modulating mammalian transcription. Nat Biotechnol 2011, 29:149-153. 10.1038/nbt.1775, 3084533, 21248753.
25. Reyon D, Tsai SQ, Khayter C, Foden JA, Sander JD, Joung JK. FLASH assembly of TALENs for high-throughput genome editing. Nat Biotechnol 2012, 30:460-465. 10.1038/nbt.2170, 3558947, 22484455.
26. Sakuma T, Hosoi S, Woltjen K, Suzuki K, Kashiwagi K, Wada H, Ochiai H, Miyamoto T, Kawai N, Sasakura Y, Matsuura S, Okada Y, Kawahara A, Hayashi S, Yamamoto T. Efficient TALEN construction and evaluation methods for human cell and animal applications. Genes Cells 2013, 18:315-326. 10.1111/gtc.12037, 23388034.
27. Bultmann S, Morbitzer R, Schmidt CS, Thanisch K, Spada F, Elsaesser J, Lahaye T, Leonhardt H. Targeted transcriptional activation of silent oct4 pluripotency gene by combining designer TALEs and inhibition of epigenetic modifiers. Nucleic Acids Res 2012, 40:5368-5377. 10.1093/nar/gks199, 3384321, 22387464.
28. Kishigami S, Wakayama S, Thuan NV, Ohta H, Mizutani E, Hikichi T, Bui HT, Balbach S, Ogura A, Boiani M, Wakayama T. Production of cloned mice by somatic cell nuclear transfer. Nat Protoc 2006, 1:125-138. 10.1038/nprot.2006.21, 17406224.
29. Chen F, Pruett-Miller SM, Huang Y, Gjoka M, Duda K, Taunton J, Collingwood TN, Frodin M, Davis GD. High-frequency genome editing using ssDNA oligonucleotides with zinc-finger nucleases. Nat Methods 2011, 8:753-755. 10.1038/nmeth.1653, 3617923, 21765410.
30. Wei C, Liu J, Yu Z, Zhang B, Gao G, Jiao R. TALEN or Cas9 - rapid, efficient and specific choices for genome modifications. J Genet Genomics 2013, 40:281-289. 10.1016/j.jgg.2013.03.013, 23790627.
31. Ding Q, Regan SN, Xia Y, Oostrom LA, Cowan CA, Musunuru K. Enhanced efficiency of human pluripotent stem cell genome editing through replacing TALENs with CRISPRs. Cell Stem Cell 2013, 12:393-394. 10.1016/j.stem.2013.03.006, 23561441.
32. Ran FA, Hsu PD, Lin CY, Gootenberg JS, Konermann S, Trevino AE, Scott DA, Inoue A, Matoba S, Zhang Y, Zhang F. Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity. Cell 2013, 154:1380-1389. 10.1016/j.cell.2013.08.021, 23992846.